Hunter Gillies, CHIEF MEDICAL OFFICER at Aerovate Therapeutics, Inc. (AVTE), sold 7,914 shares at $21.07 ($167K) on 2024-05-17, disclosed to the SEC on 2024-05-17.
Scheduled sale ($167k) by CHIEF MEDICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.07 | 3,914 | $82K | 49.4% |
| 2 | $21.07 | 3,914 | $82K | 49.4% |
| 3 | $21.86 | 86 | $2K | 1.1% |
| Total | $21.08 avg | 7,914 | $167K | 100% |
| Filing → |
| AVTE | SELL | 2024-04-01 | $266K | — | Filing → |
| AVTE | SELL | 2024-03-20 | $346K | — | Filing → |
| AVTE | SELL | 2024-03-11 | $440K | — | Filing → |